A detailed history of Kovack Advisors, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Kovack Advisors, Inc. holds 13,862 shares of VTRS stock, worth $154,422. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,862
Previous 14,500 4.4%
Holding current value
$154,422
Previous $154,000 3.9%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$10.32 - $12.13 $6,584 - $7,738
-638 Reduced 4.4%
13,862 $160,000
Q2 2024

Aug 02, 2024

SELL
$10.05 - $12.02 $17,738 - $21,215
-1,765 Reduced 10.85%
14,500 $154,000
Q1 2024

Apr 19, 2024

SELL
$11.27 - $13.53 $7,314 - $8,780
-649 Reduced 3.84%
16,265 $194,000
Q4 2023

Feb 02, 2024

SELL
$8.77 - $10.85 $19,171 - $23,718
-2,186 Reduced 11.45%
16,914 $183,000
Q3 2023

Oct 19, 2023

BUY
$9.59 - $11.35 $4,075 - $4,823
425 Added 2.28%
19,100 $188,000
Q2 2023

Jul 21, 2023

SELL
$9.02 - $10.29 $2,660 - $3,035
-295 Reduced 1.56%
18,675 $186,000
Q1 2023

Apr 20, 2023

BUY
$9.2 - $12.26 $174,524 - $232,572
18,970 New
18,970 $182,000
Q2 2022

Aug 10, 2022

SELL
$9.95 - $12.27 $5,223 - $6,441
-525 Reduced 2.62%
19,516 $204,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $4,659 - $7,315
475 Added 2.43%
20,041 $218,000
Q4 2021

Jan 18, 2022

SELL
$12.09 - $14.68 $82,079 - $99,662
-6,789 Reduced 25.76%
19,566 $265,000
Q3 2021

Nov 03, 2021

BUY
$13.25 - $15.13 $29,640 - $33,845
2,237 Added 9.28%
26,355 $357,000
Q2 2021

Jul 29, 2021

BUY
$12.97 - $16.15 $402 - $500
31 Added 0.13%
24,118 $345,000
Q1 2021

May 04, 2021

BUY
$13.59 - $18.54 $106,409 - $145,168
7,830 Added 48.16%
24,087 $336,000
Q4 2020

Jan 14, 2021

BUY
$14.3 - $18.74 $232,475 - $304,656
16,257 New
16,257 $305,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.